Why the study?
Do ARBs or ACE inhibitors reduce the increased risk of mortality and stenosis progression in patients with aortic stenosis and hypertension?
Do ARBs or ACE inhibitors reduce the increased risk of mortality and stenosis progression in patients with aortic stenosis and hypertension?
In patients with aortic stenosis and hypertension, ARBs, but not ACE inhibitors, appear to mitigate the increased mortality risk associated with hypertension.
Supports ARB preference over ACE inhibitors for hypertension in aortic stenosis; leaves open confirmation in randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Capoulade et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: